Skip to content

Exponent

US · EXPO #2429 by market cap Listed 1970
89.16 +0.16 +0.18%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Price chart

Pre-market 87.76 -1.39%
After-hours 89.16 0.00%
89.1655.1389.162026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on EXPO?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Bullish
  • Recent price momentum is +30.7% on average (3-month/1-year).
  • Main-fund capital flow has been a net inflow over the last 45 sessions.
  • Short interest has fallen to 5.1% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bullish
  • Price is above its 20-day average and above its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days C → C

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 08:27 UTC

Data coverage: 6 of 6 factors. Missing data is not a zero score.

Overall B+
ValuationGrowthProfitMomentumHealthAnalyst
Valuation C-

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 38.4x Better than 14%
Forward P/E 32.9x Better than 15%
Price / Sales 6.3x Better than 17%
P/E vs own 5-yr range 31st pctl Better than 76%
Growth B-

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 4.3% Better than 44%
Net income CAGR (3Y) 1.2% Better than 43%
Free cash flow CAGR (3Y) 14.4% Better than 59%
Profitability A-

How much profit the business keeps from each dollar of sales and capital.

Gross margin 33.0% Better than 37%
Operating margin 20.6% Better than 78%
Net margin 18.2% Better than 76%
Return on equity 26.1% Better than 85%
Return on invested capital 20.4% Better than 90%
Momentum A+

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return 27.6% Better than 98%
6-month return 55.8% Better than 96%
12-month return (ex latest month) 11.6% Better than 49%
Distance below 52-week high 2.0% Better than 98%
Financial Health A

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 2.4x Better than 64%
Debt to assets 10.7% Better than 68%
Interest coverage 54,820.0x Better than 100%
Free cash flow / net income 115.4% Better than 49%
Analyst View C-

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 75.0% Better than 51%
Upside to average target 1.7% Better than 5%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W +2.12%
1M +22.89%
3M +29.08%
6M +54.60%
YTD +30.15%
1Y +32.37%
3Y +19.59%
5Y -23.99%

Key statistics

Price & volume

Prev close
89.00
Open
89.05
Day range
89.04 - 90.98
Avg price
89.80
Volume
534.14K
Turnover
47.97M
Amplitude
2.17%
52-week range
51.41 - 90.98

Valuation

P/E
43.07
P/E (TTM)
38.43
P/B
13.77
EPS
2.07
Net profit
98.43M
Net assets
307.90M

Share structure

Market cap
4.24B
Float cap
4.18B
Shares out
47.55M
Float shares
46.91M

Dividend & listing

Dividend (TTM)
1.23
Listing date
1970-01-01
52-week range 95% of range
51.41 90.98

2.0% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

+1.12M net over the window

Short interest

Shares short
2.42M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Exponent (EXPO)?

Exponent last traded at 89.16. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Exponent's market cap?

About 4.24B.

What is the P/E ratio of Exponent?

The trailing twelve-month P/E is 38.43, below its own 5-year average of 43.50 — toward the bottom of its historical range (30.86% percentile). See the Valuation tab for the full history.

Does Exponent pay a dividend?

Yes. The trailing dividend yield is 1.38%. The 2025 payout was up 7.1% from 2024. See the Dividends tab for the full payment history.

Is Exponent a buy according to analysts?

The consensus of 4 analysts is a Buy rating, with an average 12-month price target of 90.67, which implies 1.7% upside from the current price. This is not investment advice.

What is Exponent's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Exponent a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 19:30:00 · For reference only, not investment advice and not tailored to your situation.

Exponent discussion 0 comments

Add a comment